# Study on B-blockers to Prevent Decompensation of Cirrhosis With HTPortal

> **NCT01059396** · PHASE4 · COMPLETED · sponsor: **Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau** · enrollment: 201 (actual)

## Conditions studied

- Portal Hypertension Gastropathy
- Esophageal Varices
- Spontaneous Bacterial Peritonitis
- Hepatic Encephalopathy
- Ascites

## Interventions

- **DRUG:** propranolol
- **DRUG:** carvedilol
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01059396
- **Lead sponsor:** Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01-28
- **Primary completion:** 2015-07-15
- **Final completion:** 2015-07-15
- **Target enrollment:** 201 (ACTUAL)
- **Last updated:** 2017-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01059396

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01059396, "Study on B-blockers to Prevent Decompensation of Cirrhosis With HTPortal". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01059396. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*